Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials

Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials

Abstract Background The comparative efficacy of inhaled corticosteroid/long-acting muscarinic antagonist/long-acting β2-agonist (ICS/LAMA/LABA) triple therapy administered via single or multiple inhalers in patients with chronic obstructive pulmonary disease (COPD) has not been evaluated comprehensi...

Full description

Bibliographic Details
Main Authors: Gary T. Ferguson, Nicola Brown, Chris Compton, Thomas C. Corbridge, Kelly Dorais, Charles Fogarty, Catherine Harvey, Morrys C. Kaisermann, David A. Lipson, Neil Martin, Frank Sciurba, Marjorie Stiegler, Chang-Qing Zhu, David Bernstein
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Respiratory Research
Subjects:
Triple therapy
COPD
Lung function
Symptoms
Long-acting β2-agonist (LABA)
Long-acting muscarinic antagonist (LAMA)
Online Access:http://link.springer.com/article/10.1186/s12931-020-01360-w

Internet

http://link.springer.com/article/10.1186/s12931-020-01360-w

Similar Items